NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage biopharmaceutical company...
Avadel Pharmaceuticals announced today that the FDA has granted tentative approval to LUMRYZ, a once-at-bedtime...
At the end of last year, WUN marked an incredible milestone in its fundraising efforts....
Over the past 14 years, WUN co-founder Monica Gow has assumed various roles at the...
Wake Up Narcolepsy—a nonprofit organization dedicated to fostering Narcolepsy awareness, education and research toward improved...
Founder and Executive Director of WUN, Monica Gow is a contributor to an interesting article...
WUN recently participated in a roundtable discussion with the Society for Women’s Health Research (SWHR)...
Narcolepsy and idiopathic hypersomnia usually begin in early adolescence, but diagnostic delays ranging 5-10 years...
We are excited to offer three FREE learning opportunities beginning in June - with more...
- Clinically meaningful results with Mazindol ER exhibiting a 39% reduction in ESS from baseline...
